Rethinking Perimenopause: New Research, Treatments, and Access Gaps
Penn Medicine researchers describe perimenopause as a distinct transitional phase with symptoms like mood changes, sleep disruption, and brain fog, highlighting evolving treatment views as estrogen therapy regains attention after FDA changes, while noting prescribing variation by specialty and insurance disparities. The work also aims to uncover brain mechanisms and markers to predict who benefits from hormone therapy and other treatments, emphasizing early consultation with specialists for personalized care.













